PPS: Risk Factors, Health Models, Management and Prevention of CHD Flashcards
(141 cards)
What are the top two causes of death in the UK?
- Cancer
2. CVD
What are non modifiable risk factors?
Factors we cannot change like: Age Gender Ethnicity Family history of CVD
Why is age an important non modifiable risk factor?
–Risk of developing CHD increases with age
Men: Age > 45 years
Women: Age > 55 years
–A family history of early heart disease is a risk factor
Male member of Family < 55 years
Female member of family < 60 years
Why is ethnicity an important non-modifiable risk factor?
Higher risk of hypertension and stroke in African and Caribbean population
Higher risk of coronary heart disease in South Asians
What regions have a high risk of ischaemic heart disease?
Asia and Middle East
What are modifiable risk factors?
Factors we can change like
Smoking
Hypertension
Dyslipidaemia (high cholesterol)
How much do the 3 modifiable risk factors increase chances of CVD separately and together?
Smoking: 1.6x
High Cholesterol: 4x
High BP: 3x
Together: 16x
What did Framingham heart study show in regards to BP?
Even if someone has slightly higher than normal BP = 3 fold Increase in the risk of cardiovascular disease (at a huge risk)
Hypertension treatment
Low sodium diet
Moderate alcohol
Increase exercise
Medication
How does smoking affect risk of CVD?
Consume of > 20 cigarettes daily = 2 to 3 fold increase in total heart disease
In some countries, smoking by women is on rise
Cessation of cigarette smoking constitutes the single most important preventive measure for CHD
What did the Framingham heart study find regarding high cholesterol?
The higher the cholesterol level, the greater the risk of CHD
10% reduction in total cholesterol results in
–15% reduction in CHD mortality (P<0.001)
–11% reduction in total mortality (P<0.001)
Cholesterol reduction is primary target to prevent CHD
What countries have the highest cholesterol levels? (and lowest)
Northern Europe
United States
Lowest in Japan
What are lipoproteins?
Types of cholesterol particles:
- Triglyceride-rich lipoproteins: chylomicrons and very low-density lipoprotein (VLDL)
- Cholesterol-rich lipoproteins:
LDL and HDL
LDL cholesterol
Strongly associated with atherosclerosis and CHD events
10% increase in LDL = approximate 20% increase in CHD risk
Most plasma cholesterol is in LDL particles
Smaller denser LDL are more atherogenic than larger, less dense particles
Risk associated with LDL-C increased by other risk factors: –Low HDL-C –Smoking –Hypertension –Diabetes
What is a normal cholesterol level
5, going up to 7 causes problems
HDL cholesterol
Protective effect for risk of atherosclerosis and CHD
Epidemiological studies show the lower the HDL-C level, the higher the risk for atherosclerosis and CHD
–low level (<1 mmol/L) increases risk
HDL-C inversely related to TGs
HDL-C is lowered by smoking, obesity and physical inactivity
Triglycerides
May be associated with increased risk of CHD events
Link with increased CHD risk is complex
–May be direct effect of smaller TG-rich lipoproteins and/or
–May be related to:
- low HDL levels
- highly atherogenic forms of LDL-C
- hyperinsulinaemia/insulin resistance
- procoagulation state
- hypertension
- abdominal obesity
Familial
hypercholesterolaemia (FH)
Inherited disease
Mutations in 3 genes: LDLR, APOB and PCSK9
1 in 250-500 in most populations, 110,000 in UK
CHD risk: over 50% by age 50 M, over 30% by age 60 F
Tendon Xanthoma
Cholesterol deposits as nodules attached to tendons
Seen in hands and legs of patients with FH
Corneal arcus
Can be indicative of FH in patient under 45 (white ring around iris)
Simon Broome criteria
Diagnosis of Familial Hypercholesterolaemia
Total cholesterol > 7.5 mmol/L
Low density lipoprotein cholesterol (LDL-C) > 4.9 mmol/L
Family history of premature coronary artery disease
Hypercholesteraemia treatment
Lose weight
Diet (reduce sugar) and Exercise
Medication
Effect of lipid modifying medication on lipid fractions
Percentage change:
Statins, Fibrate (mainly for cholesterol) and Ezetimibe: all reduce LDL + TG, increase HDL
How do PCSK9 inhibitors work?
LDL receptor takes LDL inside cells to remove it and then repeats (LDLR recycling)
PCSK9 attaches to LDLR and doesn’t let it function
PCSK9 inhibitor stops these particles so LDLR recycling is able to continue